Diagnosis
Acute pancreatitis
Inflammation of the pancreas due to parenchymal autodigestion by proteolytic enzymes.
Etiology
Cause [4gs][dcs]
PANCREATITIS: Perforated ulcer, Alcohol, Neoplasm, Cholelithiasis, Renal disease, ERCP, Anorexia, Trauma, Infections, Toxins, Incineration, Surgery/Scorpion bite
Hyperlipidemia, Hypercalcemia (hyperparathyroidism), Trauma, Surgery, ERCP, pancreatic cancer, pancreatic divisum, Vasculitis, Scorpion/snake venom
Viral infection: mumps, coxsackie B, CMV, EBV, hepatitis virus, echovirus, varicella-zoster virus, measles virus, and rubella virus
Bacterial infection: Mycoplasma pneumoniae, Salmonella, Campylobacter, Mycobacterium tuberculosis, Ascaris, and AIDS
Drugs: Azathioprine, Sulfonamides, Sulindac, Tetracycline, Valproic acid, Didanosine, Methyldopa, Estrogens, Furosemide, 6-Mercaptopurine, Pentamidine, 5-aminosalicylic acid compounds, Corticosteroids, Octreotide, Metronidazole, cimetidine, isoniazid, glucocorticoids
Hereditary pancreatitis: PRSS1, CFTR, SPINK1
Tumor: pancreatic ductal carcinoma, ampullary carcinoma, islet cell tumor, solid pseudotumor of the pancreas, sarcoma, lymphoma, cholangiocarcinoma, cystic neoplasms (IPMN, mucinous or serous cystadenoma), metastatic tumor
Autoimmune pancreatitis: rare, prevalence 0.82 per 100,000, related to Ig-G4
Pathophysiology
Obstruction of pancreatic digestive enzymes and activation within the pancreas leads to organ injury and Pancreatitis
Complications[5hg]
Multi organ failure
Prolonged/recurrent disease --> chronic pancreatitis (irreversible pancreatic damage)
Severe pancreatitis: [dcs]
Organ failure: sBP < 90 mmHg, [Pa O2] < 60 mm Hg, renal failure, GI hemorrhage
Local complications (eg, necrosis, abscess, pseudocyst)
Ranson score ≥ 3 or APACHE score ≥ 8
Epidemiology
Incidence per 100.000 [4gs][a2t][bnn][dfy][b7h][sc5][uv6][piv][5hg]
Symptoms & findings
Symptoms
Cullen's sign, Diarrhea, Dry mucous membranes, Fever, Flat neck veins, Fox's sign, Grey Turner's sign, Hypotension, Hypothermia, Icterus, Ileus, Narrow pulse pressure, Nausea, Oliguria, Poor skin turgor, Prolonged capillary refill, Tachycardia, Tachypnea, Vomiting, Weight loss
Clinical findings
Cholestasis, Decreased Base Excess, Decreased hematocrit, Elevated ALP, Elevated Amylase, Elevated ASAT, Elevated Blood Urea Nitrogen, Elevated CRP, Elevated GGT, Elevated Lactic Dehydrogenase, Elevated Lipase, Hemoperitoneum, Hyperglycemia, Hypocalcemia, Hyponatremia, Hypoxemia, Jaundice, Leukocytosis, Pancreatic necrosis, Pancreatic pseudocysts, Sentinel loop sign
Anamneses
Localized findings
Approach
Blood test: Amylase, lipase, ASAT, ALAT, GGT, ALP, creatinine, electrolytes, glucose, complete blood count, CRP, LD
Blood gas
Abdominal x-ray
Ultrasound abdomen
CT abdomen
ERCP
MRCP
CT-guided or EUS-guided aspiration/drainage
Genetic testing
Treatment
Fluid resuscitation [dcs]
Nutritional support
Antibiotics:
Imipenem if complicated by infected pancreatic necrosis
Antibiotic prophylaxis in severe pancreatitis is controversial
Surgery:
Gallstone pancreatitis: Cholecystectomy
Pancreatic duct obstruction: drainage tube, ERCP-stent, distal pancreatectomy or a Whipple procedure
Pseudocysts: large or symptomatic -> aspiration/drainage:
percutaneous, endoscopic, surgical management
Infected pancreatic necrosis: aspiration or surgical necrosectomy
Abscess: drainage and antibiotics --> if no response: surgical debridement and drainage
Differential diagnoses
Acute mesenteric ischemia, Acute respiratory distress syndrome, Aortic dissection, Cholangitis, Cholecystitis, Choledocholithiasis, Cholelithiasis, Chronic pancreatitis, Colorectal cancer, Gastric cancer, Gastritis, Gastroenteritis, Gastrointestinal obstruction, Hypovolemia, Irritable bowel syndrome, Macroamylasemia, Macrolipasemia, Malabsorption, Myocardial infarction, Pancreatic cancer, Pancreatic pseudocyst, Perforated ulcer, Peritonitis, Pneumonia, Ruptured aortic aneurysm, Shock, Ulcer disease, Viral hepatitis
References
[1] Iannuzzi JP, King JA, Leong JH, Quan J, Windsor JW, Tanyingoh D, Coward S, Forbes N, Heitman SJ, Shaheen AA, Swain M, Buie M, Underwood FE, Kaplan GG. Global Incidence of Acute Pancreatitis Is Increasing Over Time: A Systematic Review and Meta-Analysis. Gastroenterology. 2022 Jan;162(1):122-134.
[2] http://emedicine.medscape.com/article/181364 (2014-01-02); [Medscape]
[3] Li, T., Qin, C., Zhao, B. et al. Global and regional burden of pancreatitis: epidemiological trends, risk factors, and projections to 2050 from the global burden of disease study 2021. BMC Gastroenterol 24, 398 (2024).
[4] Li CL, Jiang M, Pan CQ, Li J, Xu LG. The global, regional, and national burden of acute pancreatitis in 204 countries and territories, 1990-2019. BMC Gastroenterol. 2021 Aug 25;21(1):332.
[5] Oskarsson V, Hosseini S, Discacciati A, et al. Rising incidence of acute pancreatitis in Sweden: National estimates and trends between 1990 and 2013. United European Gastroenterology Journal. 2020;8(4):472-480.
[6] Sellers ZM, MacIsaac D, Yu H, Dehghan M, Zhang KY, Bensen R, Wong JJ, Kin C, Park KT. Nationwide Trends in Acute and Chronic Pancreatitis Among Privately Insured Children and Non-Elderly Adults in the United States, 2007-2014. Gastroenterology. 2018 Aug;155(2):469-478.e1.
[7] Roberts SE, Akbari A, Thorne K, Atkinson M, Evans PA. The incidence of acute pancreatitis: impact of social deprivation, alcohol consumption, seasonal and demographic factors. Aliment Pharmacol Ther. 2013 Sep;38(5):539-48.
[8] Knudsen JS, Heide-Jørgensen U, Mortensen FV, Sørensen HT, Ehrenstein V. Acute pancreatitis: 31-Year trends in incidence and mortality - A Danish population-based cohort study. Pancreatology. 2020 Oct;20(7):1332-1339.
[9] Jiang W, Du Y, Xiang C, Li X, Zhou W. Age-period-cohort analysis of pancreatitis epidemiological trends from 1990 to 2019 and forecasts for 2044: a systematic analysis from the Global Burden of Disease Study 2019. Front Public Health. 2023 Jun 9;11:1118888.
[10] Wen, Y., Luo, Y., Huang, Y. et al. Global, regional, and national pancreatitis burden and health inequality of pancreatitis from 1990 to 2019 with a prediction from 2020 to 2034. BMC Public Health 24, 3329 (2024).